Drugs and Vaccination

(asked on 1st May 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to his Department’s consultation entitled Cost effectiveness methodology for vaccination programmes, published in February 2018, how many medicines and vaccines were approved for funding in England in each of the last five years with a cost per QALY of greater than £15,000; what the names of those medicines and vaccines were; and how many patients have received those medicines and vaccines.


Answered by
Steve Brine Portrait
Steve Brine
This question was answered on 8th May 2018

In relation to vaccines approved for funding in each of the last five years, a cost per quality-adjusted life year threshold of £20,000 has been used not £15,000.

An assessment has been produced of the impact on the price that we would be willing to pay for existing vaccine programmes were we to adopt recommendations in the Cost Effectiveness Methodology for Immunisation Programmes and Procurement report that is currently out for consultation. One of these recommendations is to change the threshold from £20,000 to £15,000. This assessment is based on commercially confidential information, therefore the requested information cannot be provided.

The information requested in relation to medicines could only be obtained at disproportionate cost.

Reticulating Splines